CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in TP53

Authors:

Top Cited Papers
Open Access
Abstract
Malignant T-cell transformation after chimeric antigen receptor (CAR) T-cell therapy has been described, but the contribution of CAR integration to oncogenesis is not clear. Here we report a case of a T-cell lymphoma harboring a lentiviral integration in a known tumor suppressor, TP53, which developed in a patient with multiple myeloma after B-cell maturation antigen (BCMA) CAR T-cell therapy.
Funding Information
  • National Cancer Institute (P30 CA008748, R01 CA241762)
  • Leukemia and Lymphoma Society

This publication has 29 references indexed in Scilit: